NMRA vs ROP
Neumora Therapeutics, Inc. (NMRA) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
NMRA currently screens at market cap $283.5M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the NMRA and ROP stock pages for the full models.
Not investment advice.